@trixxxy19's peptide therapy claims need fact-checking

What did @trixxxy19 actually say?

The creator listed four peptides she's currently using: retatrutide (which she calls "Retta"), melanotan II (MT2), GHK-Cu (which she calls "GHQ"), and NAD+. She framed all four as safe, low-side-effect interventions she personally endorses. She also suggested viewers "tell ChatGPT your goals" to figure out which peptides to take, and promoted a custom stack available through her bio link with a discount code.

She described retatrutide as a "GLP-3" and credited it with 12 pounds of weight loss over six to seven weeks. She called MT2 "the tanning peptide," acknowledged nausea as a side effect, and described GHK-Cu as making her skin "in the best shape of its life." NAD+ was described as something that "ages you backwards." These are specific efficacy and safety claims, and some of them deserve real scrutiny.

Does the science back this up?

Partially, but with serious gaps and at least one claim that is flat-out wrong. Retatrutide is a legitimate investigational compound, but MT2 carries documented cancer risk signals that she glossed over. GHK-Cu has promising but early-stage evidence. NAD+ is overhyped in the form she's probably using it.

Retatrutide is a triple agonist (GIP, GLP-1, and glucagon receptors), not a "GLP-3" as she claimed. That receptor class doesn't exist as a standard clinical designation. A Phase 2 trial published by Jastreboff et al. (2023, New England Journal of Medicine) showed 17.5% body weight reduction over 48 weeks at the highest dose, which is genuinely compelling data. MT2 is a synthetic analog of alpha-melanocyte-stimulating hormone. It does produce skin darkening, but a review by Langan et al. (2021, JAMA Dermatology) flagged that stimulating melanocortin receptors non-selectively raises concern for activating existing nevi and potentially promoting melanoma. That risk was not mentioned in this video. GHK-Cu peptide has shown collagen synthesis and wound-healing activity in cell and animal studies (Pickart et al., 2015, Journal of Aging Research), but robust human clinical trials are limited. NAD+ precursor supplementation has some evidence for cellular energy metabolism (Yoshino et al., 2021, Science), but calling it something that "ages you backwards" is not a claim the current literature supports.

What did they get wrong (or right)?

She got the mechanism of retatrutide wrong and omitted MT2's most serious risk. She got a few things legitimately right. The nausea with MT2 is real and well-documented. Retatrutide does appear to outperform semaglutide on weight loss endpoints in early trial data, so her preference switch from a prior GLP-1 is not unreasonable on the face of it. GHK-Cu's skin and hair effects have at least some biological plausibility.

But recommending ChatGPT as a tool for building a peptide stack is genuinely dangerous advice. Large language models do not have access to your labs, your medical history, your current medications, or any knowledge of drug interactions specific to you. Framing it as a research shortcut normalizes replacing clinical judgment with a chatbot. That's not a minor slip. Many of these peptides, including MT2, are not FDA-approved and are sold as research chemicals. Stacking multiple unregulated compounds without clinical oversight compounds the risk of each individual compound. The video presents this entire picture as "easy, cheap, and efficient" with essentially no downside, which is not an accurate representation of the risk profile.

What should you actually know?

If you're interested in any of these compounds, the single most useful thing you can do is work with a licensed clinician who can order baseline labs, review your history, and monitor you. That is not a bureaucratic suggestion. It is how you avoid finding out about side effects the hard way.

Here is what the evidence actually looks like for each compound she mentioned:

• Retatrutide: Real Phase 2 data. Genuinely promising for weight loss. Not yet FDA-approved as of this writing. Requires prescription and medical monitoring for blood sugar, heart rate, and GI effects.
• MT2 (Melanotan II): Not FDA-approved. Produces tanning via melanocortin receptor stimulation. Associated with nausea, spontaneous erections, and, more seriously, changes in moles and potential melanoma risk signals. Using it "until you reach your desired goal" with no dermatologic monitoring is not a safe protocol.
• GHK-Cu: Interesting peptide with preclinical evidence for wound healing and collagen production. Human clinical data is thin. Skin and hair claims are plausible but not confirmed in large trials.
• NAD+ (as an IV or supplement): Has legitimate research interest in cellular aging and metabolic function, but "ages you backwards" is not a claim the science supports. Yoshino et al. (2021, Science) showed NMN supplementation improved muscle insulin sensitivity in postmenopausal women. That is a long way from reversing aging.

None of these compounds should be selected based on a TikTok video or a ChatGPT prompt. A telehealth provider who can review your labs and goals is the appropriate starting point.